Importantly, they also provide further evidence supporting the notion that MT3‐MMP down‐regulation might contribute to tumorigenesis of ESCC, thereby correlating to poor prognosis of patients with ESCC. Here, MT3 is linked to esophageal squamous cell carcinoma.